Dianthus Therapeutics
Clinical trials sponsored by Dianthus Therapeutics, explained in plain language.
-
New CIDP drug aims to keep nerve damage at bay
Disease control Recruiting nowThis study tests an experimental drug called DNTH103 (claseprubart) against a placebo in 256 adults with chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve disorder that causes weakness and disability. The goal is to see if the drug can delay or prevent relapses an…
Phase: PHASE3 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated May 26, 2026 08:42 UTC
-
New drug could reduce infusions for rare nerve disease
Disease control Recruiting nowThis study tests a new medicine called DNTH103 for adults with multifocal motor neuropathy (MMN), a rare nerve condition that causes muscle weakness. The goal is to see if the drug is safe and can help people go longer between their regular immunoglobulin treatments. About 36 adu…
Phase: PHASE2 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated May 20, 2026 11:57 UTC